🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of the protocol is to evaluate the safety, efficacy, an...
Status
Completed
Location
Multiple Locations
Start Date
2007-08
Trial ID
NCT00529087
Treatments Being Tested
This is a double-blind, randomized, study at a single clinical site investi...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2002-10
Trial ID
NCT01367561
Treatments Being Tested
This study will employ a single-center, randomized, double-blind parallel-g...
Status
Completed
Location
Progenics Pharmaceuticals
Start Date
2004-11
Trial ID
NCT01363323
Treatments Being Tested
It is hypothesized that using methylnaltrexone in addition to pain killer n...
Status
Withdrawn
Location
Hahnemann University Hospital
Start Date
2010-10
Trial ID
NCT01360372
Treatments Being Tested
This double-blind, randomized, two-cohort, placebo-controlled, parallel gro...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2006-10
Trial ID
NCT01366365
Treatments Being Tested
Ticagrelor is associated with more prompt and potent antiplatelet effects c...
Status
Completed
Location
University of Florida
Start Date
2015-08
Trial ID
NCT02403830
Treatments Being Tested
To determine the efficacy of subcutaneous MNTX to relieve opioid-induced co...
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2004-02
Trial ID
NCT00402038
Treatments Being Tested
This randomized controlled trial will prospectively evaluate the clinical b...
Status
Completed
Location
Ohio State University
Start Date
2019-02-21
Trial ID
NCT03852524
Treatments Being Tested
To test the effectiveness of MNTX in advanced illness subjects....
Status
Completed
Location
Progenics Pharmaceuticals, Inc.
Start Date
2003-02
Trial ID
NCT00401362
Treatments Being Tested
MNTX 3201 is a Phase 3, international, multicenter, randomized, double-blin...
Status
Completed
Location
PRA International
Start Date
2010-09-01
Trial ID
NCT01186770
Treatments Being Tested